DIADEMA PARTNERS LP
Clone Performance
Feb 2025–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 38% of reported value on average across 6 quarters. Past performance does not predict future results.
Portfolio Concentration
110 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $569,565,326 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LQDA | Liquidia Corp | +690,219 | 712,100 | $26,874,654 | |
| REPL | Replimune Group, Inc. | +535,063 | 766,060 | $5,860,359 | |
| KOD | Kodiak Sciences Inc. | +410,462 | 440,062 | $16,775,163 | |
| CAPR | Capricor Therapeutics, Inc. | +361,176 | 1,031,551 | $31,359,150 | |
| AVXL | Anavex Life Sciences Corp. | +337,000 | 477,600 | $1,466,232 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +298,011 | 351,111 | $5,136,753 | |
| QURE | uniQure N.V. | +233,400 | 580,200 | $9,486,270 | |
| ABVX | Abivax S.A. | +200,300 | 275,944 | $30,726,364 | |
| COGT | Cogent Biosciences, Inc. | +190,912 | 322,764 | $12,423,186 | |
| EWTX | Edgewise Therapeutics, Inc. | +182,500 | 212,500 | $6,693,750 | |
| RVMD | Revolution Medicines, Inc. | +169,352 | 206,372 | $20,069,677 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +125,026 | 187,307 | $3,081,200 | |
| IMCR | Immunocore Holdings plc | +122,889 | 193,189 | $5,824,648 | |
| BHVN | Biohaven Ltd. | +117,000 | 317,000 | $2,681,820 | |
| EQ | Equillium, Inc. | +86,451 | 433,844 | $867,688 | |
| HRMY | Harmony Biosciences Holdings, Inc. | +85,364 | 92,864 | $2,601,120 | |
| INCY | Incyte Corp | +83,429 | 183,429 | $17,264,337 | |
| UTHR | UNITED THERAPEUTICS Corp | +77,503 | 87,503 | $51,887,528 | |
| PCVX | Vaxcyte, Inc. | +55,199 | 78,171 | $4,542,516 | |
| FHTX | Foghorn Therapeutics Inc. | +49,314 | 79,944 | $382,132 | |
| AYTU | Aytu Biopharma, Inc | +47,289 | 353,077 | $963,900 | |
| IVA | Inventiva S.A. | +18,148 | 352,399 | $1,955,814 | |
| NVO | Novo Nordisk A S | +17,377 | 70,477 | $2,590,029 | |
| ROIV | Roivant Sciences Ltd. | +17,100 | 335,800 | $9,301,660 | |
| TLPH | Talphera, Inc. | +16,640 | 153,563 | $115,172 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MNKD | Mannkind Corp | −667,697 | 186,603 | $457,177 | |
| NTLA | Intellia Therapeutics, Inc. | −329,300 | 200,000 | $2,564,000 | |
| BBIO | BridgeBio Pharma, Inc. | −324,289 | 85,311 | $6,335,194 | |
| BIOA | BioAge Labs, Inc. | −233,764 | 60,000 | $1,049,400 | |
| TERN | Terns Pharmaceuticals, Inc. | −228,828 | 181,752 | $9,581,965 | |
| LPCN | Lipocine Inc. | −210,939 | 50,000 | $399,500 | |
| RLMD | Relmada Therapeutics, Inc. | −188,553 | 200,842 | $1,397,860 | |
| ANNX | Annexon, Inc. | −172,984 | 486,116 | $2,693,082 | |
| VKTX | Viking Therapeutics, Inc. | −158,068 | 1,184,381 | $38,539,757 | |
| SLS | SELLAS Life Sciences Group, Inc. | −124,900 | 300,000 | $1,269,000 | |
| ZYME | Zymeworks Inc. | −119,868 | 142,132 | $3,558,985 | |
| VTGN | Vistagen Therapeutics, Inc. | −101,072 | 105,428 | $60,093 | |
| VIR | Vir Biotechnology, Inc. | −100,400 | 88,800 | $795,648 | |
| TRVI | Trevi Therapeutics, Inc. | −75,521 | 21,663 | $258,439 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −64,856 | 35,144 | $736,266 | |
| CORT | Corcept Therapeutics Inc | −63,745 | 168,500 | $6,792,235 | |
| TENX | Tenax Therapeutics, Inc. | −63,432 | 179,738 | $2,874,010 | |
| JNJ | Johnson & Johnson | −62,673 | 53,771 | $13,143,783 | |
| JAZZ | Jazz Pharmaceuticals plc | −50,545 | 54,755 | $10,351,432 | |
| XERS | Xeris Biopharma Holdings, Inc. | −37,822 | 132,746 | $769,926 | |
| TGTX | Tg Therapeutics, Inc. | −16,355 | 206,928 | $6,874,148 | |
| OLMA | Olema Pharmaceuticals, Inc. | −12,100 | 84,000 | $1,252,440 | |
| CRSP | CRISPR Therapeutics AG | −6,400 | 106,300 | $5,056,691 | |
| ATYR | aTYR PHARMA INC | −2,600 | 24,700 | $19,266 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −1,360 | 96,940 | $43,287,587 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 250,000 | $16,477,500 | |
| MRK | Merck & Co., Inc. | 100,000 | $12,029,000 | |
| MRNA | Moderna, Inc. | 159,400 | $8,097,520 | |
| ABBV | AbbVie Inc. | 24,058 | $5,232,374 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 555,257 | $5,213,863 | |
| RCUS | Arcus Biosciences, Inc. | 238,142 | $5,143,867 | |
| EYPT | EyePoint, Inc. | 284,845 | $3,671,652 | |
| ALMS | Alumis Inc. | 131,200 | $2,890,336 | |
| CELC | Celcuity Inc. | 23,014 | $2,626,817 | |
| VYGR | Voyager Therapeutics, Inc. | 573,642 | $2,214,258 | |
| BCYC | Bicycle Therapeutics PLC | 476,424 | $2,210,607 | |
| INDV | Indivior Pharmaceuticals, Inc. | 71,376 | $2,175,540 | |
| CLYM | Climb Bio, Inc. | 286,126 | $1,959,963 | |
| STTK | Shattuck Labs, Inc. | 293,664 | $1,888,259 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 25,942 | $1,819,831 | |
| ALKS | Alkermes plc. | 50,000 | $1,768,000 | |
| MGNX | Macrogenics Inc | 600,000 | $1,734,000 | |
| CTMX | CytomX Therapeutics, Inc. | 316,000 | $1,485,200 | |
| KPTI | Karyopharm Therapeutics Inc. | 241,300 | $1,344,041 | |
| IOVA | Iovance Biotherapeutics, Inc. | 302,900 | $1,063,179 | |
| OCGN | Ocugen, Inc. | 500,000 | $905,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 10,000 | $839,200 | |
| PHVS | Pharvaris N.V. | 29,321 | $828,318 | |
| IBRX | ImmunityBio, Inc. | 106,300 | $815,321 | |
| LRMR | Larimar Therapeutics, Inc. | 166,637 | $749,866 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc. | 100,600 | $29,650,844 | |
| QQQ | Invesco Qqq Trust, Series 1 | 30,000 | $18,429,300 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 15,300 | $11,809,611 | |
| INSM | INSMED Inc | 52,800 | $9,189,312 | |
| IONS | Ionis Pharmaceuticals Inc | 106,200 | $8,401,482 | |
| OCUL | Ocular Therapeutix, Inc | 545,200 | $6,618,728 | |
| ANIP | Ani Pharmaceuticals Inc | 53,354 | $4,211,764 | |
| SLNO | Soleno Therapeutics Inc | 79,992 | $3,703,629 | |
| AQST | Aquestive Therapeutics, Inc. | 548,800 | $3,545,248 | |
| RXRX | Recursion Pharmaceuticals, Inc. | 741,900 | $3,034,371 | |
| CNTA | Centessa Pharmaceuticals plc | 111,100 | $2,778,611 | |
| GOSS | Gossamer Bio, Inc. | 877,100 | $2,719,010 | |
| ABUS | Arbutus Biopharma Corp | 548,600 | $2,638,766 | |
| IRWD | Ironwood Pharmaceuticals Inc | 683,611 | $2,303,769 | |
| ONC | BeOne Medicines Ltd. | 7,500 | $2,278,575 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5,341 | $2,123,848 | |
| TECX | Tectonic Therapeutic, Inc. | 100,600 | $2,098,516 | |
| PTGX | Protagonist Therapeutics, Inc | 22,700 | $1,982,618 | |
| TVTX | Travere Therapeutics, Inc. | 50,300 | $1,921,963 | |
| ALT | Altimmune, Inc. | 491,800 | $1,775,398 | |
| VNDA | Vanda Pharmaceuticals Inc. | 200,000 | $1,764,000 | |
| LEGN | Legend Biotech Corp | 69,000 | $1,500,060 | |
| BCRX | Biocryst Pharmaceuticals Inc | 190,928 | $1,489,238 | |
| ARDX | Ardelyx, Inc. | 252,198 | $1,470,314 | |
| ASND | Ascendis Pharma A/S | 6,840 | $1,458,561 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
PUT
CALL
+ SHARES
Healthcare
|
Added | 87,503 | $51,887,528 | 9.11% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
CALL
+ SHARES
Healthcare
|
Reduced | 96,940 | $43,287,587 | 7.60% | |
| VKTX |
Viking Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 1,184,381 | $38,539,757 | 6.77% | |
| CAPR |
Capricor Therapeutics, Inc.
PUT
CALL
+ SHARES
Healthcare
|
Added | 1,031,551 | $31,359,150 | 5.51% | |
| ABVX |
Abivax S.A.
PUT
CALL
+ SHARES
Healthcare
|
Added | 275,944 | $30,726,364 | 5.39% | |
| LQDA |
Liquidia Corp
PUT
CALL
Healthcare
|
Added | 712,100 | $26,874,654 | 4.72% | |
| RVMD |
Revolution Medicines, Inc.
PUT
+ SHARES
Healthcare
|
Added | 206,372 | $20,069,677 | 3.52% | |
| APGE |
Apogee Therapeutics, Inc.
CALL
Healthcare
|
Added | 222,500 | $18,727,825 | 3.29% | |
| INCY |
Incyte Corp
PUT
+ SHARES
Healthcare
|
Added | 183,429 | $17,264,337 | 3.03% | |
| KOD |
Kodiak Sciences Inc.
PUT
CALL
+ SHARES
Healthcare
|
Added | 440,062 | $16,775,163 | 2.95% | |
| CYTK |
Cytokinetics Inc
PUT
CALL
Healthcare
|
NEW | 250,000 | $16,477,500 | 2.89% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 53,771 | $13,143,783 | 2.31% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 322,764 | $12,423,186 | 2.18% | |
| MRK |
Merck & Co., Inc.
PUT
Healthcare
|
NEW | 100,000 | $12,029,000 | 2.11% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Reduced | 54,755 | $10,351,432 | 1.82% | |
| GPCR |
Structure Therapeutics Inc.
PUT
+ SHARES
Healthcare
|
Added | 199,734 | $9,627,178 | 1.69% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 181,752 | $9,581,965 | 1.68% | |
| QURE |
uniQure N.V.
PUT
CALL
+ SHARES
Healthcare
|
Added | 580,200 | $9,486,270 | 1.67% | |
| ROIV |
Roivant Sciences Ltd.
PUT
Healthcare
|
Added | 335,800 | $9,301,660 | 1.63% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 148,229 | $8,373,456 | 1.47% | |
| MRNA |
Moderna, Inc.
PUT
Healthcare
|
NEW | 159,400 | $8,097,520 | 1.42% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Reduced | 206,928 | $6,874,148 | 1.21% | |
| CORT |
Corcept Therapeutics Inc
CALL
+ SHARES
Healthcare
|
Reduced | 168,500 | $6,792,235 | 1.19% | |
| EWTX |
Edgewise Therapeutics, Inc.
CALL
Healthcare
|
Added | 212,500 | $6,693,750 | 1.18% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 85,311 | $6,335,194 | 1.11% | |
| REPL |
Replimune Group, Inc.
PUT
CALL
+ SHARES
Healthcare
|
Added | 766,060 | $5,860,359 | 1.03% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 193,189 | $5,824,648 | 1.02% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 6,000 | $5,518,620 | 0.97% | |
| ABBV |
AbbVie Inc.
Healthcare
|
NEW | 24,058 | $5,232,374 | 0.92% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 555,257 | $5,213,863 | 0.92% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
NEW | 238,142 | $5,143,867 | 0.90% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Added | 351,111 | $5,136,753 | 0.90% | |
| CRSP |
CRISPR Therapeutics AG
CALL
Healthcare
|
Reduced | 106,300 | $5,056,691 | 0.89% | |
| PCVX |
Vaxcyte, Inc.
CALL
+ SHARES
Healthcare
|
Added | 78,171 | $4,542,516 | 0.80% | |
| EYPT |
EyePoint, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 284,845 | $3,671,652 | 0.64% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Reduced | 142,132 | $3,558,985 | 0.62% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 187,307 | $3,081,200 | 0.54% | |
| ALMS |
Alumis Inc.
PUT
CALL
Healthcare
|
NEW | 131,200 | $2,890,336 | 0.51% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Reduced | 179,738 | $2,874,010 | 0.50% | |
| ANNX |
Annexon, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 486,116 | $2,693,082 | 0.47% | |
| BHVN |
Biohaven Ltd.
CALL
Healthcare
|
Added | 317,000 | $2,681,820 | 0.47% | |
| CELC |
Celcuity Inc.
CALL
+ SHARES
Healthcare
|
NEW | 23,014 | $2,626,817 | 0.46% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Added | 92,864 | $2,601,120 | 0.46% | |
| NVO |
Novo Nordisk A S
PUT
+ SHARES
Healthcare
|
Added | 70,477 | $2,590,029 | 0.45% | |
| NTLA |
Intellia Therapeutics, Inc.
CALL
Healthcare
|
Reduced | 200,000 | $2,564,000 | 0.45% | |
| VYGR |
Voyager Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 573,642 | $2,214,258 | 0.39% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
NEW | 476,424 | $2,210,607 | 0.39% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
NEW | 71,376 | $2,175,540 | 0.38% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
NEW | 286,126 | $1,959,963 | 0.34% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 352,399 | $1,955,814 | 0.34% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.